Co-administration of antibody-drug conjugate

HK40137433APending Publication Date: 2026-09-11IKSUDA THERAPEUTICS LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
HK62026125396
Authority / Receiving Office
HK · HK
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-08-30
Filing Date
2026-06-26
Publication Date
2026-09-11

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

The present invention relates to antibody-drug conjugates (ADCs) targeting CanAg and the combined administration of ADCs with non-targeting antibodies. In particular, the present invention relates to compositions (e.g., pharmaceutical compositions) comprising an ADC and a non-targeting antibody and methods of using the compositions, including treating cancer.
Need to check novelty before this filing date? Find Prior Art